Vikram is a partner in Putnam’s London office and is focused on expanding Putnam’s commercial strategy practice in the UK and Europe.
He brings over 20 years of consulting experience having worked with multiple clients globally to make more informed decisions related to asset, disease, and portfolio strategy. Vikram’s core areas of focus include commercial opportunity assessments, early pipeline strategy, BD&L (Business Development & Licensing) due diligence and portfolio strategy. He has worked across several therapeutic areas specializing in oncology, immunology, rare diseases, cardiovascular, metabolic and renal diseases. His previous roles include corporate development strategy and banking.
Vikram earned his Bachelor’s and MBA from the Lubin School of Business at Pace University and was inducted to the Beta Gamma Sigma honor society.